Esophageal cancer

Schottenfeld and Fraumeni Cancer Epidemiology and Prevention, Fourth Edition

Volumn , Issue , 2017, Pages 579-592

  Blot, William J ^a   Tarone, Robert E ^b  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

Author keywords

Adenocarcinoma; Cancer; Esophagus; Obesity; Smoking; Squamous cell carcinoma

Indexed keywords

EID: 85051026958     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/oso/9780190238667.003.0030     Document Type: Chapter

References (200)

1. Abedi-Ardekani B, Hainaut P. 2014. Cancers of the upper gastro-intestinal tract: a review of somatic mutation distributions. Arch Iran Med 17:286-292. PMID: 24724606.
2. Abnet CC, Corley DA, Freedman ND, Kamangar F. 2015. Diet and upper gastrointestinal malignancies. Gastroenterol 148:1234-1243. PMCID: PMC4414068.
3. Abnet CC, Freedman ND, Hu N, Wang Z, Yu K, Shu XO, et al. 2010. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nature Genet 9:764-767. PMCID: PMC2947317.
4. Agaku IT, King BA, Dube SR. 2014. Current cigarette smoking among adults: United States, 2005-2012. MMWR 63:29-34. PMID: 24430098.
5. Akhtar S. 2013. Areca nut chewing and esophageal squamous-cell carcinoma risk in Asians: a meta-analysis of case-control studies. Cancer Causes Control 24:257-265. PMID: 23224324.
6. Al-Samawi AS, Aulaqi SM. 2014. Esophageal cancer in Yemen. J Coll Physicians Surg Pak 24:182-185. PMID: 24613114.
7. Andrici J, Cox MR, Eslick GD. 2013. Cigarette smoking and the risk of Barrett's esophagus: a systematic review and meta-analysis. J Gastroenterol Hepatol 28:1258-1273. PMID: 23611750.
8. Andrici J, Eslick GD. 2013. Maté consumption and the risk of esophageal squamous cell carcinoma: a meta-analysis. Dis Esophagus 26:807-816. PMID: 22891687.
9. Andrici J, Eslick GD. 2015. Hot food and beverage consumption and the risk of esophageal cancer: a meta-analysis. Am J Prev Med 49:952-960. PMID: 26590941.
10. Arnold M, Soerjomataram I, Ferlay J, Forman D. 2015. Global incidence of oesophageal cancer by histological subtype in 2012. Gut 64:381-387. PMID: 25320104.
11. ATBC Study Group. 1994. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330:1029-1035. PMID: 8127329.
12. Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, Fedirko V, et al. 2015. Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer 112:580-593. PMCID: PMC4453639.
13. Beales ILP, Vardi I, Dearman L, Broughton T. 2013. Statin use is associated with a reduction in the incidence of esophageal adenocarcinoma: a case control study. Dis Esophagus 26:838-846. PMID: 22989236.
14. Beales ILP, Dearman L, Vardi I, Loke Y 2016. Reduced risk of Barrett's esophagus in statin users: case-control study and meta-analysis. Dig Dis Sci 61:238-246. PMID: 26386857.
15. Blaser MJ. 1999. Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis 179:1523-1530. PMID: 10228075.
16. Blaser MJ. 2008. Disappearing microbiota: Helicobacter pylori protection against esophageal adenocarcinoma. Cancer Prev Res 1:308-311. PMID: 19138974.
17. Blaydon DC, Etheridge SL, Risk JM, Hennies HC, Gay LJ, Carroll R, et al. 2012. RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome. Am J Hum Genet 90:340-346. PMCID: PMC3276661.
18. Blot WJ. 1992. Alcohol and cancer. Cancer Res 52:2119s-2123s. PMID: 1544150.
19. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, et al. 1993. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and dis ease-specific mortality in the general population. J Natl Cancer Inst 85:1483-1492. PMID: 8360931.
20. Blot WJ. 1994. Esophageal cancer trends and risk factors. Semin Oncol 21:403-410. PMID: 8042037.
21. Blot WJ, Devesa SS, Kneller RW, Fraumeni JFF Jr. 1991. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265:1287-1289. PMID: 1995976.
22. Blot WJ, McLaughlin JK, Fraumeni JF Jr. 2006. Esophageal cancer. In: Schottenfeld D, Fraumeni JFJr (eds.), Cancer epidemiology and prevention, 3rd ed. New York: Oxford University Press, pp. 697-706.
23. Bosetti C, Levi F, Ferlay J, Garavello W, Lucchini F, Bertuccio P, et al. 2008. Trends in oesophageal cancer incidence and mortality in Europe. Int J Cancer 122:1118-1129. PMID: 17990321.
24. Brennan P, Lewis S, Hashibe M, Bell DA, Boffetta P, Bouchardy C, et al. 2004. Pooled analysis of alcohol dehydrogenase genotypes and head and neck cancer: a HuGE review. Am J Epidemiol 159:1-16. PMID: 14693654.
25. Buas MF, Levine DM, Makar KW, Utsugi H, Onstad L, Li X, et al. 2014. Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma. Carcinogenesis 35:2740-2747. PMCID: PMC4247522.
26. Buas MF, Onstad L, Levine DM, Risch HA, Chow WH, Liu G, et al. 2015. MiRNA-related SNPs and risk of esophageal adenocarcinoma and Barrett's esophagus: post genome-wide association analysis in the BEACON consortium. PLoS One 10(6):e0128617. doi: 10.1371/journal. pone.0128617. PMCID: PMC4454432.
27. Chandar AK, Iyer PG. 2015. Role of obesity in the pathogenesis and progression of Barrett's esophagus. Gastroenterol Clin N Am 44:249-264. PMID: 26021193.
28. Chang CM, Corey CG, Rostron BL, Apelberg BJ. 2015. Systematic review of cigar smoking and all cause and smoking related mortality. BMC Public Health Apr 24;15:390. doi: 10.1186/s12889-015-1617-5. PMCID: PMC4408600.
29. Chang JS, Straif K, Guha N. 2012. The role of alcohol dehydrogenase genes in head and neck cancers: a systematic review and meta-analysis of ADH1B and ADH1C. Mutagenesis 27:275-286. PMID: 22042713.
30. Chang P, Friedenberg F. 2014. Obesity and GERD. Gastroenterol Clin N Am 43:161-173. PMCID: PMC3920303.
31. Chen H, Ward MH, Graubard BJ, Heineman EF, Markin RM, Potischman NA, et al. 2002. Dietary patterns and adenocarcinoma of the esophagus and distal stomach. Am J Clin Nutr 75:137-144. PMID: 11756071.
32. Chen X, Yang C. 2001. Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis 22:1119-1129. PMID: 11470739.
33. Chen Y, Tong Y, Yang C, Gan Y, Sun H, Bi H, et al. 2015. Consumption of hot beverages and foods and risk of esophageal cancer: meta-analysis of observational studies. BMC Cancer 15:449. PMCID: PMC4457273.
34. Chow WH, Blot WJ, Vaughn TL, Risch HA, Gammon MD, Stanford JL, et al. 1998. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 90:150-155. PMID: 9450576.
35. Chow WH, Finkle WD, McLaughlin JK, Frankl H, Ziel HK, Fraumeni JF Jr. 1995. The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA 274:474-477. PMID: 7629956.
36. Chung CC, Lee YC, Wu MS. 2015. Prevention strategies for esophageal cancer: perspective of the East vs. West. Best Practices Res Clin Gastroenterol 29:869-883. PMID: 26651249.
37. Conio M, Blanchi S, Lapertosa G, Ferraris R, Sablich R, Marchi S, et al. 2003. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study. Am J Gastroenterol 98:1931-1939. PMID:14499768.
38. Cook MB, Corley DA, Murray LJ, Liao LM, Kamangar F, Ye W, et al. 2014. Gastroesophageal reflux in relation to adenocarcinomas of the esophagus: a pooled analysis from the Barrett's and Esophageal Adenocarcinoma consortium. PLoS One 9:e103508. PMCID: PMC4116205.
39. Cook MB, Kamangar F, Whiteman DC, Freedman ND, Gammon M, Bernstein L, et al. 2010. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst 102:1344-1353. PMCID: PMC2935475.
40. Cook MB, Shaheen NJ, Anderson LA, Giffen C, Chow WH, Vaughan TL, et al. 2012. Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. Gastroenterol 142:744-753. PMCID: PMC3321098.
41. Corley DA, Kubo A, Zhao W. 2007. Abdominal obesity, ethnicity and gastro- oesophageal reflux symptoms. Gut 56:756-762. PMCID: pMc1954862.
42. Corley DA, Kubo A, Zhao W. 2008. Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev 17:352-358. PMCID: PMC2670999.
43. Cross AJ, Freedman ND, Ren J, Ward MH, Hollenbeck AR, Schatzkin A, et al. 2011. Meat consumption and risk of esophageal and gastric cancer in a large prospective study. Am J Gastroenterol 106:432-442. PMCID: PMC3039705.
44. Davis FG, Krestinina LY, Preston D, Epifanova S, Degteva M, Akleyev AV. 2015. Solid cancer incidence in the Techna River Incidence Cohort. Radiation Res 184:56-65. PMID: 26121228.
45. Drahos J, Xiao Q, Risch HA, Freedman ND, Abnet CC, Anderson LA, et al. 2016. Age-specific risk factor profiles of adenocarcinomas of the esophagus: a pooled analysis from the international BEACON consortium. Int J Cancer 138:55-64. PMCID: PMC4607633.
46. Dulak AM, Stojanov P, Peng S, Lawrence MS, Fox C, Stewart C, et al. 2013. Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nature Genet 45:478-486. PMCID: PMC3678719.
47. Dunbar KB, Souza RF, Spechler SJ. 2015. The effect of proton pump inhibitors on Barrett's esophagus. Gastroenterol Clin N Am 44:415-424. PMID: 26021202.
48. Dura P, van Veen EM, Salomon J, te Morsche RHM, Roelofs HMJ, Kristinsson JO, et al. 2013a. Barrett associated MHC and FOXF1 variants also increase esophageal carcinoma risk. Int J Cancer 133:1751-1756. PMID: 23504527.
49. Dura P, Bregitha CVV, te Morsche RHM, Roelofs HMJ, Kristinsson JO, Wobbes T, et al. 2013b. GWAS-uncovered SNPs in PLCE1 and RFT2 genes are not implicated in Dutch esophageal adenocarcinoma and squamous cell carcinoma etiology. Eur J Cancer Prev 22:417-19. PMID: 23222411.
50. Eckardt AJ, Eckardt VF. 2010. Cancer surveillance in achalasia: better late than never? Am J Gastroenterol 105:2150-2152. PMID: 20927062.
51. Ek WE, Levine DM, D'Amato M, Pedersen NL, Magnusson PKE, Bresso F, et al. 2013. Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux. J Natl Cancer Inst 105:1711-1718. PMCID: PMC3833931.
52. El-Serag HB, Hollier JM, Gravitt P, Alsarraj A, Younes M. 2013. Human papillomavirus and the risk of Barrett's esophagus. Dis Esophagus 26:517 PMCID: PMC4412355.
53. Falk GW. 2015. Barrett's oesophagus: frequency and prediction of dysplasia and cancer. Best Pract Res Clin Gastroenterol 29:125-138. PMCID: PMC4352690.
54. Fishbach LA, Nordenstedt H, Kramer JR, Gandhi S, Dick-Onuoha S, Lewis A, El-Serag HB. 2012. The association between Barrett's esophagus and Helicobacter pylori infection: a meta-analysis. Helicobacter 17:163-175. PMCID: PMC3335759.
55. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. 2013. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer. Available from: http://globocan.iarc.fr, accessed August 27, 2015.
56. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. 2015. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359-E386. PMID: 25220842.
57. Freedman ND, Abnet CC, Leitzmann MF, Mouw T, Subar AF, Hollenbeck AR, Schatzkin A. 2007. A prospective study of Tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol 165:14241433. PMID: 17420181.
58. Freedman ND, Murray LJ, Kamangar F, Abnet CC, Cook MB, Nyrén O, et al. 2011. Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON consortium. Gut 60:1029-1037. PMCID: PMC3439838.
59. Friedenberg FK, Xanthopoulos M, Foster GD, Richter JE. 2008. The association between gastroesophageal reflux disease and obesity. Am J Gastroenterol 103:2111-2122. PMID: 18796104.
60. Galipeau PC, Li X, Blount PL, Maley CC, Sanchez CA, Odze RD, et al. 2007. NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma. PLoS Med 4:e67. PMCID: PMC1808095.
61. Gao Y, Hu N, Han XY, Giffen C, Ding T, Goldstein A, Taylor P. 2009. Family history of cancer and risk for esophageal and gastric cancer in Shanxi, China. BMC Cancer 9:269. PMCID: PMC2729777.
62. Gao YB, Chen ZL, Li JG, Hu XD, Shi XJ, Sun ZM, et al. 2014. Genetic landscape of esophageal squamous cell carcinoma. Nature Genet 46:1097-1102. PMID: 25151357.
63. Gatenby P, Caygill C, Wall C, Bhatacharjee S, Ramus J, Watson A, Winslet M. 2014. Lifetime risk of esophageal adenocarcinoma in patients with Barrett's esophagus. World J Gastroenterol 20:9611-9617. PMCID: PMC4110596.
64. Goodman M, Morgan RW, Ray R, Malloy CD, Zhao K. 1999. Cancer in asbestos-exposed occupational cohorts: a meta-analysis. Cancer Causes Control 10:453-465. PMID: 10530617.
65. Grantzau T, Overgaard J. 2015. Risk of second non-breast cancer after radiotherapy for breast cancer: a systematic review and meta-analysis of 762,468 patients. Radiother Oncol 114:56-65. PMID: 25454172.
66. Hardefeldt HA, Cox MR, Eslick GD. 2014. Association between human papillomavirus (HPV) and oesophageal squamous cell carcinoma: a metaanalysis. Epidemiol Infect 142:1119-1137. PMID: 24721187.
67. Hoyo C, Cook MB, Kamangar F, Freedman ND, Whiteman DC, Bernstein L, et al. 2012. Body mass index in relation to oesophageal and oesopha- gogastric junction adenocarcinomas: a pooled analysis from the international BEACON consortium. Int J Epidemiol 41:1706-1718. PMCID: PMC3535758.
68. Hur C, Miller M, Kong CY, Dowling EC, Nattinger KJ, Dunn M, Feuer EJ. 2013. Trends in esophageal adenocarcinoma incidence and mortality. Cancer 119:1149-1158. PMCID: PMC3744155.
69. International Agency for Research on Cancer (IARC). 1986. Tobacco smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 38. Lyon, France: IARC. PMID: 3460963.
70. International Agency for Research on Cancer (IARC). 1988. Alcohol drinking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 44. Lyon, France: IARC. PMID: 3236394.
71. International Agency for Research on Cancer (IARC). 2004. Tobacco smoke and involuntary smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 83. Lyon, France: IARC. PMCID: PMC4781536.
72. International Agency for Research on Cancer (IARC). 2012a. Biologic agents. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 100B. Lyon, France: IARC. PMCID: PMC4781184.
73. International Agency for Research on Cancer (IARC). 2012b. Personal habits and indoor combustions. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 100E. Lyon, France: IARC. PMCID: PMC4781577.
74. International Agency for Research on Cancer (IARC). 2014. Trichloroethylene, tetrachloroethylene, and some other chlorinated agents. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 106. Lyon, France: IARC. PMCID: PMC4781308.
75. Islami F, Boffetta P, Ren JS, Pedoeim L, Khatib D, Kamangar F. 2009. High- temperature beverages and foods and esophageal cancer risk: a systematic review. Int J Cancer 125:491-524. PMCID: PMC2773211.
76. Islami F, Fedirko V, Tramacere I, Bagnardi V, Jenab M, Scotti L, et al. 2011. Alcohol drinking and esophageal squamous cell carcinoma with focus on light-drinkers and never-smokers: a systematic review and meta-analysis. Int J Cancer 129:2473-2484. PMID: 21190191.
77. Islami F, Kamangar F. 2008. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res 1:329-338. PMCID: PMC3501739.
78. Jiang X, Tseng CC, Bernstein L, Wu AH. 2014. Family history of cancer and gastroesophageal disorders and risk of esophageal and gastric adenocarcinomas: a case-control study. BMC Cancer 14:60. PMCID: PMC3915076.
79. Kaakoush NO, Castano-Rodriguez N, Man SM, Mitchell HM. 2015. Is Campylobacter to esophageal adenocarcinoma as Helicobacter is to gastric adenocarcinoma? Trends Microbiol 23:455-462. PMID: 25937501.
80. Kamiya K, Ozasa K, Akiba S, Niwa O, Kodama K, Takamura N, et al. 2015. From Hiroshima and Nagasaki to Fukushima 1: long-term effects of radiation exposure on health. Lancet 386:469-478. PMID: 26251392.
81. Kong CY, Kroep S, Curtius K, Hazleton WD, Jeon J, Meza R, et al. 2014. Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling. Cancer Epidemiol Biomarkers Prev 23:997-1006. PMCID: PMC4048738.
82. Koshiol J, Wei WQ, Kreimer AR, Chen W, Gravitt P, Ren JS. 2010. No role for human papillomavirus in esophageal squamous cell carcinoma in China. Int J Cancer 127:93-100. PMCID: PMC3069961.
83. Krishnamoorthi R, Borah B, Heien H, Das A, Chak A, Iyer P. 2016. Rates and predictors of progression to esophageal carcinoma in a large population-based esophagus cohort. Gastrointest Endosc 84:40-46. PMID: 26772891.
84. Kroep S, Lansdorp-Vogelaar I, Rubenstein JH, Lemmens VEPP, van Heijningen EB, Aragonés N, et al. 2014. Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, Spain, and The Netherlands. Am J Gastroenterol 109:336-343. PMID: 24343546.
85. Kubo A, Corley DA, Jensen CD, Kaur R. 2010. Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's esophagus. Nutr Res Rev 23:230-246. PMCID: PMC3062915.
86. Kubo A, Corley DA. 2006. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 15:872-878. PMID: 16702363.
87. Lada MJ, Nieman DR, Han M, Timratana P, Alsalahi O, Peyre CG, et al. 2013. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in oesophageal adenocarcinoma: trends revisited. Surgery 154:856-866. PMID: 24074425.
88. Lagergren J. Influence of obesity on the risk of esophageal disorders. 2011. Nat Rev Gastroenterol Hepatol 8:340-347. PMID: 21643038.
89. Lagergren J, Bergstrom R, Lindgren A, Nyrén O. 2000. The role of Tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer 85:340-346. PMID: 10652424.
90. Lagergren J, Bergstrom R, Nyrén O. 1999. Association between body mass index and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 130:883-890. PMID: 10375336.
91. Lagergren J, Lagergren P. 2013. Recent developments in esophageal adenocarcinoma. CA Cancer J Clin 63:232-248. PMID: 23818335.
92. Lam TK, Freedman ND, Fan JH, Qiao YL, Dawsey SM, Taylor PR, Abnet CC. 2013. Prediagnostic plasma vitamin C and risk of gastric adenocarcinoma and esophageal squamous cell carcinoma in a Chinese population. Am J Clin Nutr 98:1289-1297. PMCID: PMC3798080.
93. Lambert JD, Yang CS. 2003. Mechanisms of cancer prevention by tea constituents. J Nutr 133:3262s-3267s. PMID: 14519824.
94. Lee PN, Hamling J. 2009. Systematic review of the relation between smokeless Tobacco and cancer in Europe and North America. BMC Medicine 7:36. PMCID: PMC2744672.
95. Leeuwenburgh I, Scholten P, Caljé TJ, Vaessen RJ, Tilanus HW, Hansen BE, Kuipers EJ. 2013. Barrett's esophagus and esophageal adenocarcinoma are common after treatment for achalasia. Dig Dis Sci 58:244-252. PMID: 23179142.
96. Levine DM, Ek WE, Zhang R, Liu X, Onstad L, Sather C, et al. 2013. A genome- wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nature Genet 45:1487-1493. PMCID: PMC3840115.
97. Li X, Gao C, Yang Y, Zhou F, Li M, Jin Q, Gao L. 2014. Systematic review with meta-analysis: the association between human papillomavirus infection and oesophageal cancer. Aliment Pharmacol Ther 39:270-281. PMID: 24308856.
98. Li WQ, Hu N, Hyland PL, Gao Y, Wang ZM, Yu K, et al. 2013a. Genetic variations in DNA repair pathway genes and risk of esophageal squamous cell carcinoma and gastric adenocarcinoma in a Chinese population. Carcinogenesis 34:1536-1542. PMCID: PMC3697889.
99. Li WQ, Hu N, Wang Z, Yu K, Su H, Wang L, et al. 2013b. Genetic variants in epidermal growth factor receptor pathway genes and risk of esophageal squamous cell carcinoma and gastric cancer in a Chinese population. PLoS One 8:e68999. PMCID: PMC3715462.
100. Li WQ, Park Y, Wu JW, Ren JS, Goldstein AM, Taylor PR, et al. 2013c. Index-based dietary patterns and risk of esophageal and gastric cancer in a large cohort study. Clin Gastroenterol Hepatol 11:1130-1136. PMCID: PMC3758458.
101. Liao LM, Vaughan TL, Corley DA, Cook MB, Casson AG, Kamangar F, et al. 2012. Nonsteroidal anti-inflammatory drug use reduces the risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis. Gastroenterol 142:442-452. PMCID: PMC3488768.
102. Lin DC, Hao JJ, Nagata Y, Xu L, Shang L, Meng X, et al. 2014. Genomic and molecular characterization of esophageal squamous cell carcinoma. Nature Genet 46:467-473. PMCID: PMC4070589.
103. Liu X, Wang X, Lin S, Yuan J, Yu ITS. 2014. Dietary patterns and oesophageal squamous cell carcinoma: a systematic review and meta-analysis. Br J Cancer 110:2785-2795. PMCID: PMC4037820.
104. Liyanage SS, Rahman B, Ridda I, Newall AT, Tabrizi SN, Garland SM, et al. 2013. The aetiological role of human papillomavirus in oesophageal squamous cell carcinoma: a meta-analysis. PLoS One 8:e69238. PMCID: PMC3722293.
105. Lubin JH, Cook MB, Pandeya N, Vaughan TL, Abnet CC, Giffen C, et al. 2012. The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett's Esophagus and Esophageal Adenocarcinoma Consortium. Cancer Epidemiol 36:306-316. PMCID: PMC3489030.
106. Ludmir EB, Stephens SJ, Palta M, Willett CG, Czito BG. 2015. Human papillomavirus tumor infection in esophageal squamous cell carcinoma. J Gastrointest Oncol 6:287-295. PMCID: PMC4397257.
107. Mohammed ME, Abuidris DO, Elgaili EM, Gasmelseed N. 2012. Predominance of females with oesophageal cancer in Gezira, Central Sudan. Arab J Gastroenterol 13:174-177. PMID: 23432985.
108. Morton LM, Gilbert ES, Hall P, Andersson M, Joensuu H, Vaalavirta L, et al. 2012. Risk of treatment-related esophageal cancer among breast cancer survivors. Ann Oncol 23:3081-3091. PMCID: PMC3501231.
109. Morton LM, Gilbert ES, Stovall M, van Leeuwen FE, Dores GM, Lynch CF, et al. 2014. Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma. Haematologica 99:e193. PMCID: PMC4181268.
110. Munoz N, Day NE. 1996. Esophageal cancer. In: Schottenfeld D, Fraumeni JFJr (eds.), Cancer epidemiology and prevention, 2nd ed. New York: Oxford University Press, pp. 681-706.
111. Myung SK, Yang HJ. 2013. Efficacy of vitamin and antioxidant supplements in prevention of esophageal cancer: meta-analysis of randomized controlled trials. J Cancer Prev 18:135-143. PMCID: PMC4189455.
112. National Academies of Science. 2006. Asbestos: selected cancers. Washington, DC: The National Academies Press.
113. National Cancer Institute (NCI). 1998. Cigars: health effects and trends. Smoking and Tobacco Control Mongraph 9. NIH Publication no. 984302. Bethesda, MD: NCI.
114. National Cancer Institute (NCI). 2015. DCCPS, Surveillance Research Program, Cancer Statistics Branch. SEER Program Public Use Data Tapes 1973-2012, released April 2015, based on the November 2014 submission.
115. Neto AG, Whitaker A, Pei Z. 2016. Microbiome and potential targets for che- moprevention of esophageal adenocarcinoma. Semin Oncol 43:86-96. PMC4789168.
116. Nguyen TH, Thrift AP, Ramsey D, Green L, Shaib YH, Graham DY, El-Serag HB. 2014. Risk factors for Barrett's esophagus compared between African Americans and non-Hispanic whites. Am J Gastroenterol 109:1870-1880. PMID: 25420546.
117. Nie S, Chen T, Yang X, Huai P, Lu M. 2014. Association of Helicobacter pylori infection with esophageal adenocarcinoma and squamous cell carcinoma: a meta-analysis. Dis Esophagus 27:645-653. PMID: 24635571.
118. O'Doherty MG, Cantwell MM, Murray LJ, Anderson LA, Abnet CC; on behalf of the FINBAR study group. 2011. Dietary fat and meat intakes and risk of reflux esophagitis, Barrett's esophagus and esophageal adenocarcinoma. Int J Cancer 129:1493-1502. PMCID: PMC3144995.
119. O'Doherty MG, Freedman ND, Hollenbeck AR, Schatzkin A, Abnet CC. 2012. A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH-AARP Diet and Health Study. Gut 61:1261-1268. PMCID: PMC3504700.
120. Ogden CL, Carroll MD, Kit BK, Flegal KM. 2014. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 311:806-814. PMCID: PMC4770258.
121. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. 1996. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334:1150-1155. PMID: 8602180.
122. Orloff M, Peterson C, He X, Ganapathi S, Heald B, Yang YR, et al. 2011. Germline mutations in MSR1, ASCC1, and CTHRC1 in patients with Barrett esophagus and esophageal adenocarcinoma. JAMA 306:410-19. PMCID: PMC3574553.
123. Palles C, Chegwidden L, Li X, Findlay JM, Farnham G, Giner FC, et al. 2015. Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus. Gastroenterol 148:367-378. PMCID: PMC4315134.
124. Peixoto GD, Hsin LS, Snijders P, Wilmotte R, Herrero R, Lenoir G, et al. 2001. Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in high-risk area of China. Cancer Lett 162:231-235. PMID: 11146230.
125. Petrick JL, Li N, McClain KM, Steck SE, Gammon MD. 2015. Dietary risk reduction factors for Barrett's esophagus-esophageal adenocarcinoma continuum: a review or the recent literature. Curr Nutr Rep 4:47-65. PMCID: PMC4349493.
126. Petrick JL, Wyss AB, Butler AM, Cummings C, Sun X, Poole C, et al. 2014. Prevalence of human papillomavirus among oesophageal squamous cell carcinoma cases: systematic review and meta-analysis. Br J Cancer 110:2369-2377. PMCID: PMC4007246.
127. Prabhu A, Obi KO, Rubenstein JH. 2014. The synergistic effects of alcohol and Tobacco consumption on the risk of esophageal squamous cell carcinoma: a meta-analysis. Am J Gastroenterol 109:822-827. PMID: 24751582.
128. Qiao YL, Dawsey SM, Kamangar F, Fan JH, Abnet CC, Sun XD, et al. 2009. Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. J Natl Cancer Inst 101:507-518. PMCID: PMC2664089.
129. Robertson EV, Jankowski JA. 2008. Genetics of gastroesophageal cancer: paradigms, paradoxes, and prognostic utility. Am J Gastroenterol 103:443-449. PMID: 17925001.
130. Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G. 2007. Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin Gastroenterol Hepatol 5:1413-1417. PMID: 17997357.
131. Rosekrans SL, Baan B, Muncan V, van den Brink GR. 2015a. Esophageal development and epithelial homeostasis. Am J Physiol Gastronintest Liver Physiol 309:G216-G228. PMID: 26138464.
132. Rosekrans SL, Heijmans J, Buller NVJA, Westerlund J, Lee AS, Muncan V, van den Brink GR. 2015b. ER stress induces epithelial differentiation in the mouse esophagus. Gut 64:195-202. PMID: 24789843.
133. Ross-Innes CS, Becq J, Warren A, Cheetham RK, Northern H, O'Donovan M, et al. 2015. Whole-genome sequencing provides new insights into the clonal architecture of Barrett's esophagus and esophageal adenocarcinoma. Nature Genet 47:1038-1046. PMCID: PMC4556068.
134. Rothwell PM, Fowkes FGR, Belch JFF, Ogawa H, Warlow CP, Meade TW. 2011. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomized trials. Lancet 377:31-41. PMID: 21144578.
135. Rothwell PM, Price JF, Fowkes FGR, Zanchetti A, Roncaglioni MC, Tognoni G, et al. 2012. Short-term effects of daily aspirin on cancer incidence, mortality and non-vascular death: analysis of the time course of risks and benefits in 51 randomized controlled trials. Lancet 379:1602-1612. PMID: 22440946.
136. Rubenstein JH, Inadomi JM, Scheiman J, Schoenfeld P, Appelman H, Zhang M, et al. 2014. Association between Helicobacter pylori and Barrett's esophagus, erosive esophagitis, and gastroesophageal reflux symptoms. Clin Gastroenterol Hepatol 12:239-245. PMCID: PMC3947027.
137. Rubenstein JH, Scheiman JM, Sadeghi S, Whiteman D, Inadomi JM. 2011. Esophageal adenocarcinoma incidence in individuals with gastroesophageal reflux: synthesis and estimates from population studies. Am J Gastroenterol 106:254-260. PMCID: PMC3901355.
138. Runge TM, Abrams JA, Shaheen NJ. 2015. Epidemiology of Barrett's esophagus and esophageal adenocarcinoma. Gastroenterol Clin N Am 44:203-231. PMCID: PMC4449458.
139. Rustgi AK, El-Serag HB. 2014. Esophageal carcinoma. N Eng J Med 371:2499-2509. PMID: 25539106.
140. Ryan AM, Duoung M, Healy L, Ryan SA, Parekh N, Reynolds JV, Power DG. 2011. Obesity, metabolic syndrome and esophageal adenocarcinoma: epidemiology, etiology and new targets. Cancer Epidemiol 35:309-319. PMID: 21470937.
141. Saraggi D, Fassan M, Bornschein J, Farinati F, Realdon S, Valeri N, Rugge M. 2016. From Barrett metaplasia to esophageal adenocarcinoma: the molecular background. Histol Histopathol 31:25-32. PMID: 26334343.
142. Sawada G, Niida A, Uchi R, Hirata H, Shimamura T, Suzuki Y, et al. 2016. Genomic landscape of esophageal squamous cell carcinoma in a Japanese population. Gastroenterol 150:1171-1182. PMID: 26873401.
143. Schneider JL, Corley DA. 2015. A review of the epidemiology of Barrett's oesophagus and oesophageal adenocarcinoma. Best Pract Res Clin Gastroenterol 29:29-39. PMID: 25743454.
144. Schneider JL, Zhao WK, Corley DA. 2015. Aspirin and Nonsteroidal anti- inflmmatory drug use and the risk of Barrett's esophagus. Dig Dis Sci 60:436-443. PMCID: PMC4304909.
145. Shen FF, Zhou FY, Xue QS, Pan Y, Zheng L, Zhang H, et al. 2013. Association between CYP1A1 polymorphisms and esophageal cancer: a metaanalysis. Mol Biol Rep 40:6035-6042. PMID: 24065535.
146. Siddiqi K, Shah S, Abbas SM, Vidyasagaran A, Jawad M, Dogar O, Sheikh A. 2015. Global burden of disease due to smokeless Tobacco consumption in adults: analysis of data from 113 countries. BMC Med 13:194. PMCID: PMC4538761.
147. Simard EP, Ward EM, Siegel R, Jemal A. 2012. Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin 62:118-128. PMID: 22281605.
148. Singh S, Garg SK, Singh PP, Iyer PG, El-Serag HB. 2014. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis. Gut 63:1229-1237. PMCID: PMC4199831.
149. Singh S, Goyal A, Singh PP, Murad MH, Iyer PG. 2013a. Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 11:620-629. PMCID: PMC3660516.
150. Singh S, Sharma AN, Murad MH, Buttar NS, El-Serag HB, Katzka DA, Iyer PG. 2013b. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 11:1399-1412. PMCID: PMC3873801.
151. Sinha DN, Abdulkader RS, Gupta PC. 2016. Smokeless Tobacco-associated cancers: a systematic review and meta-analysis of Indian studies. Int J Cancer 138:1368-1379. PMID: 26443187.
152. Sitas F, Egger S, Urban MI, Taylor PR, Abnet CC, Boffetta P, et al. 2012. InterSCOPE study: associations between esophageal squamous cell carcinoma and human papillomavirus serologic markers. J Natl Cancer Inst 104:147-158. PMCID: PMC3260131.
153. Song Y, Li L, Ou Y, Gao Z, Li E, Li X, et al. 2014. Identification of genomic alterations in oesophageal squamous cell cancer. Nature 509:91-95. PMID: 24670651.
154. Spechler SJ. 2013. Barrett esophagus and risk of esophageal cancer: a clinical review. JAMA 310:627-636. PMID: 23942681.
155. Spechler SJ. 2014. Does Barrett's esophagus regress after surgery (or proton pump inhibitors)? Dig Dis 32:156-163. PMID: 24603402.
156. Stachler MD, Taylor-Weiner A, Peng S, McKenna A, Agoston AT, Odze RD, et al. 2015. Paired exome analysis of Barrett's esophagus and adenocarcinoma. Nature Genet 47:1047-1055. PMCID: PMC4552571.
157. Steevens J, Schouten LJ, Goldbohm RA, van den Brandt PA. 2011. Vegetables and fruits consumption and risk of esophageal and gastric cancer subtypes in the Netherlands Cohort Study. Int J Cancer 129:2681-2693. PMID: 21960262.
158. Steffen A, Huerta JM, Weiderpass E, Bueno-de-Mesquita HB, May AM, Siersema PD, et al. 2015. General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 137:646-657. PMID: 25598323.
159. Streppel MM, Lata S, DelaBastide M, Montgomery EA, Wang JS, Canto MI, et al. 2014. Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett's esophagus. Oncogene 33:347-357. PMCID: PMC3805724.
160. Streppel MM, Montgomery EA, Maitra A. 2014. New advances in the pathogenesis and progression of Barrett's esophagus. Curr Mol Med 14:58-68. PMID: 23865431.
161. Su Z, Gay LJ, Strange A, Palles C, Band G, Whiteman DC, et al. 2012. Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nature Genet 44:1131-1136. PMCID: PMC3459818.
162. Sun L, Yu S. 2011. Meta-analysis: non-steroidal anti-tnflammatory drug use and the risk of esophageal squamous cell carcinoma. Dis Esophagus 24:544-549. PMID: 21539676.
163. Tanaka F, Yamamoto K, Suzuki S, Inoue H, Tsurumaru M, Kajiyama Y, et al. 2010. Strong interaction between the effects of alcohol consumption and smoking on oesophageal squamous cell carcinoma among individuals with ADH1B and/or ALDH2 risk alleles. Gut 59:1457-1464. PMID: 20833657.
164. Tang L, Xu, F, Zhang T, Lei J, Binns CW, Lee AHW. 2013. High temperature food and beverage intake increases the risk of oesophageal cancer in Xinjiang, China. Asian Pac J Cancer Prev 14:5085-5088. PMID: 24175780.
165. Taylor PR, Abnet CC, Dawsey SM. 2013. Squamous dysplasia: the precursor lesion for esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 22:540-552. PMCID: PMC3681095.
166. Teng H, Li X, Liu X, Wu J, Zhang J. 2014. The absence of human papillomavirus in esophageal squamous cell carcinoma in East China. Int J Exp Pathol 7:4184-4193. PMCID: PMC4129033.
167. Thrift AP. 2015. Esophageal adenocarcinoma: the influence of medications used to treat comorbidities on cancer prognosis. Clin Gastroenterol Hepatol 13:2225-2232. PMID: 25835331.
168. Thrift AP, Cook MB, Vaughan TL, Anderson LA, Murray LJ, Whiteman DC, et al. 2014a. Alcohol and the risk of Barrett's esophagus: a pooled analysis from the international BEACON consortium. Am J Gastroenterol 109:1586-1594. PMCID: PMC4189971.
169. Thrift AP, Risch HA, Onstad L, Shaheen NJ, Casson AG, Bernstein L, et al. 2014b. Risk of esophageal adenocarcinoma decreases with height, based on consortium analysis and confirmed by Mendelian randomization. Clin Gastroenterol Hepatol 12:1667-1676. PMCID: PMC4130803.
170. Thrift AP, Shaheen NJ, Gammon MD, Bernstein L, Reid BJ, Onstat L, et al. 2014c. Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study. J Natl Cancer Inst 106:dju252. doi: 10.1093/jnci/dju252. PMCID: PMC4200028.
171. Tramacere I, La Vecchia C, Negri E. 2011. Tobacco smoking and esophageal and gastric cardia adenocarcinoma: a meta-analysis. Epidemiology 22:344-349. PMID: 21330928.
172. Tramacere I, Pelucchi C, Bagnardi V, Rota M, Scotti L, Islami F, et al. 2012. A meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma risk. Ann Oncol 23:287-297. PMID: 21551004.
173. Turati F, Tramacere, I, La Vecchia C, Negri E. 2013. A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma. Ann Oncol 24:609-617. PMID: 22898040.
174. Tuyns AJ, Pequignot G, Jensen OM. 1977. [Esophageal cancer in Ille-et- Vilaine in relation to levels of alcohol and Tobacco consumption. Risks are multiplying]. Bull Cancer 64:45-60. PMID: 861389.
175. Verbeek RE, Leenders M, ten Kate FJW, van Hillegersberg R, Vleggaar FP, van Baal JWPM, et al. 2014. Surveillance of Barrett's esophagus and mortality from esophageal adenocarcinoma: a population-based cohort study. Am J Gastroenterol 109:1215-1222. PMID: 24980881.
176. Vineis P, Alavanja M, Buffler P, Fontham E, Franceschi S, Gao YT, et al. 2004. Tobacco and cancer: recent epidemiologic findings. J Natl Cancer Inst 96:99-106. PMID: 14734699.
177. Wang D, Su M, Tian D, Liang S, Zhang J. 2012. Associations between CYP1A1 and CYP2E1 polymorphisms and susceptibility to esophageal cancer in Chaoshan and Taihang areas of China. Cancer Epidemiol 36:276-282. PMID: 22088806.
178. Wang F, Lv ZS, Fu YK. 2011. Nonsteroidal anti-inflammatory drugs and esophageal inflammation-Barrett's esophagus-adenocarcinoma sequence: a meta-analysis. Dis Esophagus 24:318-324. PMID: 21166737.
179. Wang FR, Fang QQ, Tang WM, Xu XS, Mahapatra T, Liu YF, et al. 2015. Nested case-control study of occupational radiation exposure and breast and esophagus cancer risk among medical diagnostic X ray workers in Jiangsu of China. Asian Pac J Cancer Prev 16:4699-4704. PMID: 26107226.
180. Wang LD, Zhou FY, Li XM, Sun LD, Song X, Jin Y, et al. 2010. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies a susceptibility locus at PLCE1. Nature Genet 9:759-763. PMID: 20729853.
181. WCRF/AICR. 2007. Food, nutrition, physical activity, and prevention of cancer: a global perspective. Washington, DC: AICR. http://www.aicr.org/as sets/docs/pdf/reports/S econd_Expert_Report.pdf.
182. Weaver JM, Ross-Innes CS, Shannon N, Lynch AG, Forshew T, Barbera M, et al. 2014. Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis. Nature Genet 46:837-843. PMCID: PMC4116294.
183. Wild CP, Hardie LJ. 2003. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions. Nat Rev Cancer 3:676-684. PMID: 12951586.
184. Wu C, Hu Z, He Z, Jia W, Wang F, Zhou Y, et al. 2011. Genome-wide association study identifies three new susceptibility loci for esophageal squamous cell carcinoma in Chinese populations. Nature Genet 43: 679-684. PMID: 21642993.
185. Wu C, Kraft P, Zhai K, Chang J, Wang Z, Li Y, et al. 2012. Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions. Nature Genet 44:1090-1096. PMCID: PMC3513832.
186. Wu C, Li D, Jia W, Hu Z, Zhou Y, Yu D, et al. 2013. Genome-wide association study identifies common variants in SLC39A6 associated with length of survival in esophageal squamous-cell carcinoma. Nature Genet 45:632-638. PMID: 23644492.
187. Wu C, Wang Z, Song X, Feng XS, Abnet CC, He J, et al. 2014. Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations. Nature Genet 46:1001-1006. PMCID: PMC4212832.
188. Wu M, Liu AM, Kampman E, Zhang ZF, van't Veer P, Wu DL, et al. 2009. Green tea drinking, high tea temperature and esophageal cancer in high- and low-risk areas of Jiangsu Province, China: a population-based case-control study. Int J Cancer 124:1907-1913. PMID: 19123468.
189. Xie FJ, Zhang YP, Zheng QQ, Jin HC, Wang FL, Chen M, et al. 2013. Helicobacter pylori infection and esophageal cancer risk: and updated meta-analysis. World J Gastroenterol 19:6098-6107. PMCID: PMC3785633.
190. Xie SH, Lagergren J. 2016. The male predominance in esophageal adenocarcinoma. Clin Gastroenterol Hepatol 14:338-347. PMID: 26484704.
191. Xu X, Wang J, Zhu SM, Yang M, Fang Y, Zhao A, et al. 2015. Impact of alcohol dehydrogenase gene 4 polymorphisms on esophageal squamous cell carcinoma risk in a Chinese population. PLoS One 10:e0127304. doi: 10.1371/journal.pone.0127304. PMCID: PMC4454665.
192. Yokoyama A, Kato H, Yokoyama T, Tsujinaka T, Muto M, Omori T, et al. 2002. Genetic polymorphisms of alcohol and aldehyde dehydrogenases and glutathione S-transferase M1 and drinking, smoking, and diet in Japanese men with esophageal squamous cell carcinoma. Carcinogenesis 23:1851-1859. PMID: 12419833.
193. Yousef F, Cardwell C, Cantwell MM, Galway K, Johnston BT, Murray L. 2008. The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis. Am J Epidemiol 168:237-249. PMID: 18550563.
194. Zandberg DP, Bhargava R, Badin S, Cullen KJ. 2013. The role of human papillomavirus in nongenital cancers. CA Cancer J Clin 63:57-81. PMID: 23258613.
195. Zendehdel K, Nyrén O, Edberg A, Ye W. 2011. Risk of esophageal adenocarcinoma in achalasia patients, a retrospective cohort study in Sweden. Am J Gastroenterol 106:57-61. PMID: 21212754.
196. Zhang GH, Mai RQ, Huang B. 2010. Meta-analysis of ADH1B and ALDH2 polymorphisms and esophageal cancer risk in China. World J Gastroenterol 16:6020-6025. PMCID: PMC3007115.
197. Zhang L, Zhou Y, Cheng C, Cui H, Cheng L, Kong P, et al. 2015. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. Am J Hum Genet 96:597-611. PMCID: PMC4385186.
198. Zheng JS, Yang J, Fu YQ, Huang T, Li D. 2013. Effects of green tea, black tea, and coffee consumption on the risk of esophageal cancer: a systematic review and meta-analysis of observational studies. Nutr Cancer 65:1-16. PMID: 23368908.
199. Zhu HC, Yang X, Xu LP, Zhao LJ, Tao GZ, Zhang C, et al. 2014. Meat consumption is associated with esophageal cancer risk in a meat- and cancer-histological-type dependent manner. Dig Dis Sci 59:664-673. PMID: 24395380.
200. Znaor A, Brennan P, Gajalakshmi V, Mathew A, Shanta V, Varghese C, Boffetta P. 2003. Independent and combined effects of Tobacco smoking, chewing and alcohol drinking on the risk of oral, pharyngeal and esophageal cancers in Indian men. Int J Cancer 105:681-686. PMID: 12740918.